Germline mutations in BRCA1 and BRCA2 are associated with greatly increased frequency of breast and ovarian cancers and telomere shortening was associated with genetic anticipation in hereditary breast cancer [38]. This evidence concerns the gene BRCA1 and ovarian carcinoma.